158 related articles for article (PubMed ID: 3521485)
1. Novobiocin antagonism of amastigotes of Trypanosoma cruzi growing in cell-free medium.
Pate PG; Wolfson JS; McHugh GL; Pan SC; Swartz MN
Antimicrob Agents Chemother; 1986 Mar; 29(3):426-31. PubMed ID: 3521485
[TBL] [Abstract][Full Text] [Related]
2. Novobiocin-induced ultrastructural changes and antagonism of DNA synthesis in Trypanosoma cruzi amastigotes growing in cell-free medium.
Kerschmann RL; Wolfson JS; McHugh GL; Dickersin GR; Hooper DC; Swartz MN
J Protozool; 1989; 36(1):14-20. PubMed ID: 2651651
[TBL] [Abstract][Full Text] [Related]
3. Trypanosoma cruzi proliferation and differentiation are blocked by topoisomerase II inhibitors.
Gonzales-Perdomo M; de Castro SL; Meirelles MN; Goldenberg S
Antimicrob Agents Chemother; 1990 Sep; 34(9):1707-14. PubMed ID: 2178335
[TBL] [Abstract][Full Text] [Related]
4. Effects of novobiocin, coumermycin A1, clorobiocin, and their analogs on Escherichia coli DNA gyrase and bacterial growth.
Hooper DC; Wolfson JS; McHugh GL; Winters MB; Swartz MN
Antimicrob Agents Chemother; 1982 Oct; 22(4):662-71. PubMed ID: 6295263
[TBL] [Abstract][Full Text] [Related]
5. The terpenic diamine GIB24 inhibits the growth of Trypanosoma cruzi epimastigotes and intracellular amastigotes, with proteomic analysis of drug-resistant epimastigotes.
Azeredo CM; Saraiva MF; de Oliveira MR; Barbosa G; de Almeida MV; de Souza MVN; Soares MJ
Chem Biol Interact; 2020 Oct; 330():109165. PubMed ID: 32771326
[TBL] [Abstract][Full Text] [Related]
6. Trypanosoma cruzi: cell biological behavior of epimastigote and amastigote forms in axenic culture.
Engel JC; Dvorak JA
J Protozool; 1988 Nov; 35(4):513-8. PubMed ID: 3058949
[TBL] [Abstract][Full Text] [Related]
7. Resistance genes of aminocoumarin producers: two type II topoisomerase genes confer resistance against coumermycin A1 and clorobiocin.
Schmutz E; Mühlenweg A; Li SM; Heide L
Antimicrob Agents Chemother; 2003 Mar; 47(3):869-77. PubMed ID: 12604514
[TBL] [Abstract][Full Text] [Related]
8. [Trypanosoma cruzi: influence of human plasma on the morphogenesis of blood trypomastigotes in a cell-free culture media].
Zaidenberg A; Tournier H; Schinella G; Buschiazzo H
Rev Latinoam Microbiol; 1995; 37(1):71-7. PubMed ID: 7784736
[TBL] [Abstract][Full Text] [Related]
9. The activity of ketoconazole and other azoles against Trypanosoma cruzi: biochemistry and chemotherapeutic action in vitro.
Goad LJ; Berens RL; Marr JJ; Beach DH; Holz GG
Mol Biochem Parasitol; 1989 Jan; 32(2-3):179-89. PubMed ID: 2494453
[TBL] [Abstract][Full Text] [Related]
10. L-proline is essential for the intracellular differentiation of Trypanosoma cruzi.
Tonelli RR; Silber AM; Almeida-de-Faria M; Hirata IY; Colli W; Alves MJ
Cell Microbiol; 2004 Aug; 6(8):733-41. PubMed ID: 15236640
[TBL] [Abstract][Full Text] [Related]
11. [Trypanosoma cruzi: obtaining extracellular amastigotes and studying their development under different culture conditions].
Zaidenberg A; Tournier HA; Schinella GR; Buschiazzo HO
Rev Latinoam Microbiol; 2000; 42(1):21-6. PubMed ID: 10948825
[TBL] [Abstract][Full Text] [Related]
12. Production of amastigotes from metacyclic trypomastigotes of Trypanosoma cruzi.
Contreras VT; Navarro MC; De Lima AR; Arteaga R; Duran F; Askue J; Franco Y
Mem Inst Oswaldo Cruz; 2002 Dec; 97(8):1213-20. PubMed ID: 12563492
[TBL] [Abstract][Full Text] [Related]
13. Trypanosoma cruzi: characterization of an intracellular epimastigote-like form.
Almeida-de-Faria M; Freymüller E; Colli W; Alves MJ
Exp Parasitol; 1999 Aug; 92(4):263-74. PubMed ID: 10425154
[TBL] [Abstract][Full Text] [Related]
14. Changes in fibroblast-derived trypomastigotes of Trypanosoma cruzi during long-term culture.
Ashraf M; Kuhn RE
J Parasitol; 1992 Jun; 78(3):526-8. PubMed ID: 1597800
[TBL] [Abstract][Full Text] [Related]
15. Trypanosoma cruzi: adrenergic modulation of cyclic AMP role in proliferation and differentiation of amastigotes in vitro.
de Castro SL; Meirelles Mde N; Oliveira MM
Exp Parasitol; 1987 Dec; 64(3):368-75. PubMed ID: 2824234
[TBL] [Abstract][Full Text] [Related]
16. Ultrastructural analysis of edelfosine-treated trypomastigotes and amastigotes of Trypanosoma cruzi.
Santa-Rita RM; Barbosa HS; de Castro SL
Parasitol Res; 2006 Dec; 100(1):187-90. PubMed ID: 16855821
[TBL] [Abstract][Full Text] [Related]
17. Trypanosoma cruzi: inhibition by spirogermanium hydrochloride.
Tanowitz HB; Brennessel DJ; Baum SG; Salgo MP; Braunstein V; Wittner M
Exp Parasitol; 1987 Aug; 64(1):57-63. PubMed ID: 3301388
[TBL] [Abstract][Full Text] [Related]
18. Biological activity of the azlactone derivative EPA-35 against Trypanosoma cruzi.
de Azeredo CM; Ávila EP; Pinheiro DL; Amarante GW; Soares MJ
FEMS Microbiol Lett; 2017 Feb; 364(4):. PubMed ID: 28130370
[TBL] [Abstract][Full Text] [Related]
19. The induction of Trypanosoma cruzi trypomastigote to amastigote transformation by low pH.
Tomlinson S; Vandekerckhove F; Frevert U; Nussenzweig V
Parasitology; 1995 Jun; 110 ( Pt 5)():547-54. PubMed ID: 7541124
[TBL] [Abstract][Full Text] [Related]
20. Ultrastructural alterations and growth inhibition of Trypanosoma cruzi and Leishmania major induced by Bothrops jararaca venom.
Gonçalves AR; Soares MJ; de Souza W; DaMatta RA; Alves EW
Parasitol Res; 2002 Jul; 88(7):598-602. PubMed ID: 12107450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
